Really disturbing piece on Merck’s promoting of Vioxx, downplaying the heart risks. A shame. I used to think Merck was one of the more ethical of the drug companies.
A drug’s ability to prevent or cure or slow the progress of disease should stand on its own, not on $2,000 sales bonuses. [via DB's MedRants]